Cameroon vs Fiji: Previously treated cases tested for RR-/MDR-TB
Cameroon
100.0%
in 2024
Fiji
100.0%
in 2024
Cameroon rank
1st
Fiji rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Cameroon
- Fiji
How they compare
Cameroon currently reports 100.0% against 100.0% in Fiji, a difference of 0.0%.
The two have swapped places 6 times across 15 shared years of data; in 2009 it was Fiji ahead.
Cameroon ranks 1st and Fiji ranks 1st of 180 countries.
Across the 3 decades both report, Cameroon averaged higher in 1 and Fiji in 2.
Head to head by decade
| Decade | Cameroon | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.0% | 100.0% | 86.0% | Fiji |
| 2010s | 52.8% | 53.5% | 0.7% | Fiji |
| 2020s | 97.2% | 81.8% | 15.4% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Cameroon or Fiji?
- Cameroon, at 100.0% against 100.0% in Fiji as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Cameroon and Fiji?
- 0.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Fiji?
- 15 years are reported by both, from 2009 to 2024.
- How do Cameroon and Fiji rank globally for previously treated cases tested for rr-/mdr-tb?
- Cameroon ranks 1st and Fiji ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.